5
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Claiming desmopressin therapeutic equivalence in children requires pediatric data: a population PKPD analysis.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          For a new formulation of a drug, only pharmacokinetic bioequivalence with the original formulation has to be demonstrated in healthy, young adults. However, "children are not small adults," and to guarantee a safe and effective treatment, age-adapted drug development is required. Desmopressin, a vasopressin analogue prescribed for nocturnal enuresis in children, was studied as an example formulation first developed in adults and then extrapolated to a pediatric indication.

          Related collections

          Author and article information

          Journal
          Eur. J. Clin. Pharmacol.
          European journal of clinical pharmacology
          Springer Nature
          1432-1041
          0031-6970
          Mar 2018
          : 74
          : 3
          Affiliations
          [1 ] Laboratory of Medical Biochemistry and Clinical Analysis, Department of Bioanalysis, Faculty of Pharmaceutical Sciences, Ghent University, Ottergemsesteenweg 460, 9000, Ghent, Belgium. robin.michelet@ugent.be.
          [2 ] Department of Pediatric Nephrology, Ghent University Hospital, De Pintelaan 185, 9000, Ghent, Belgium. lien.dossche@ugent.be.
          [3 ] Department of Pediatric Nephrology, Ghent University Hospital, De Pintelaan 185, 9000, Ghent, Belgium.
          [4 ] Laboratory of Medical Biochemistry and Clinical Analysis, Department of Bioanalysis, Faculty of Pharmaceutical Sciences, Ghent University, Ottergemsesteenweg 460, 9000, Ghent, Belgium.
          Article
          10.1007/s00228-017-2386-0
          10.1007/s00228-017-2386-0
          29198064
          3f0c4ee6-9b44-4f6a-a811-f1274a49cecb
          History

          1-Deamino-8-D-arginine vasopressin (dDAVP),Bioequivalence,Tablet,PKPD modeling,Lyophilisate,Children

          Comments

          Comment on this article